Dana Farber/Harvard Cancer Center — Boston, Massachusetts

Dana Farber/Harvard Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana Farber/Harvard Cancer Center has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Multiple Myeloma, Cancer, Advanced Cancer.

Sponsors: Regeneron Pharmaceuticals, ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA), CASI Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber/Harvard Cancer Center?

Dana Farber/Harvard Cancer Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber/Harvard Cancer Center conducted?

Dana Farber/Harvard Cancer Center has 9 clinical trials on record, with 5 currently active. Their work covers Multiple Myeloma, Cancer, Advanced Cancer.

Is Dana Farber/Harvard Cancer Center accredited by Crixeo Health?

Yes — Dana Farber/Harvard Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dana Farber/Harvard Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.